Why should a woman with adenomyosis have a complete blood count and iron studies performed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Why Women with Adenomyosis Need CBC and Iron Studies

Women with adenomyosis should have a complete blood count and iron studies performed because adenomyosis causes chronic menstrual blood loss leading to iron deficiency in approximately 65% of cases, and this iron deficiency is frequently undiagnosed even when ferritin levels appear normal, requiring transferrin saturation measurement to detect functional iron deficiency masked by inflammation.

The Pathophysiology Behind Testing

Adenomyosis creates a unique clinical scenario where multiple mechanisms drive iron depletion:

Chronic Blood Loss

  • Adenomyosis causes heavy menstrual bleeding through endometrial tissue invasion into the myometrium
  • This results in progressive iron depletion over time, even when bleeding doesn't appear dramatically heavy to the patient
  • Importantly, 47% of adenomyosis patients without self-reported heavy menstrual bleeding still develop iron deficiency 1

The Inflammation Factor

Adenomyosis is fundamentally a chronic inflammatory condition. This creates a diagnostic challenge because:

  • Ferritin is an acute-phase reactant that becomes falsely elevated during inflammation 2, 3
  • Standard ferritin cutoffs (<20 ng/mL) miss a substantial proportion of iron-deficient patients with adenomyosis
  • The inflammatory state in adenomyosis can mask true iron deficiency by keeping ferritin in the "normal" range while actual iron stores are depleted 3

What the Testing Reveals

Complete Blood Count Findings

The CBC in adenomyosis patients shows characteristic patterns:

  • Anemia is common but represents only the tip of the iceberg - iron deficiency precedes anemia by months 4
  • Hemoglobin concentration and hematocrit are late indicators, falling only after iron stores are severely depleted 4
  • Red cell indices (MCV, RDW) help differentiate iron deficiency from other causes of anemia 5
  • Platelet counts may be elevated in anemic adenomyosis patients as a compensatory mechanism 6

Iron Studies: The Critical Details

A complete iron panel must include 7, 5:

  • Serum ferritin
  • Transferrin saturation (calculated from serum iron ÷ total iron binding capacity)
  • Complete blood count with red cell indices

Why Both Ferritin AND Transferrin Saturation Matter

This is the critical insight from recent research on adenomyosis specifically:

In adenomyosis patients, using ferritin alone misses 34.5% of iron-deficient cases 3. Here's why:

  • When using ferritin <20 ng/mL alone: detects 31% with iron deficiency
  • When using the combined criterion (ferritin <20 ng/mL OR transferrin saturation <20%): detects 65.5% with iron deficiency 3

Transferrin saturation <20% identifies functional iron deficiency - a state where ferritin appears adequate (≥20 ng/mL) but insufficient iron is available for erythropoiesis due to inflammation blocking iron utilization 7, 3. This functional iron deficiency is particularly common in adenomyosis because of its inflammatory nature.

The Diagnostic Algorithm

Initial Testing Thresholds

  1. Ferritin <20 ng/mL = absolute iron deficiency (high specificity) 2, 8
  2. Ferritin 20-45 ng/mL with transferrin saturation <20% = functional iron deficiency 7, 2, 3
  3. Transferrin saturation <20% has high sensitivity for detecting any form of iron deficiency (absolute or functional) 7

Special Consideration for Adenomyosis

The correlation between hemoglobin and transferrin saturation is weak in adenomyosis patients (r=0.21) compared to other gynecologic conditions like fibroids (r=0.55), meaning you cannot predict iron status from hemoglobin levels alone in this population 3. This makes laboratory testing mandatory rather than optional.

Clinical Impact on Morbidity and Quality of Life

Why This Matters for Patient Outcomes

Iron deficiency - even without anemia - causes:

  • Severe fatigue: Patients with iron deficiency have significantly lower fatigue scores (26.3 vs 29.8 on validated scales) 1
  • Reduced exercise capacity and breathlessness 2
  • Impaired cognitive function 2
  • Decreased work productivity and quality of life 1

The Treatment Imperative

Over 50% of endometriosis/adenomyosis patients have undiagnosed iron deficiency 1. Without testing, these patients continue suffering preventable symptoms while their iron stores progressively deplete.

The British Society of Gastroenterology emphasizes that iron deficiency should be detected and treated before anemia develops, as waiting for anemia means patients have already experienced months of preventable symptoms 2.

Common Pitfalls to Avoid

  1. Don't rely on patient-reported bleeding severity: Nearly half of iron-deficient adenomyosis patients don't report heavy menstrual bleeding 1

  2. Don't use ferritin alone in inflammatory conditions: The inflammation in adenomyosis makes ferritin unreliable as a sole marker 3

  3. Don't wait for anemia to develop: Iron deficiency causes significant morbidity before hemoglobin drops 2

  4. Don't assume normal ferritin means adequate iron: Check transferrin saturation - it identified iron deficiency in 35.7% of adenomyosis patients with ferritin ≥30 ng/mL 1

The Bottom Line

Testing is not optional - it's essential for identifying a highly prevalent, treatable condition that significantly impairs quality of life. The combination of CBC and complete iron studies (including both ferritin and transferrin saturation) provides the diagnostic accuracy needed to detect iron deficiency in adenomyosis patients, where inflammation obscures standard markers and symptoms are often attributed to the underlying gynecologic condition rather than recognized as treatable iron deficiency 3, 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.